LBT-3627 / Longevity Biotech 
Welcome,         Profile    Billing    Logout  
 0 Diseases   1 Trial   1 Trial   4 News 
1 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
LBT-3627 / Longevity Biotech
NCT06466525: A Two-Part Single and Multiple Ascending Dose Trial of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LBT-3627 in Healthy Participants and in Participants With Parkinson's Disease.

Recruiting
1
64
RoW
LBT-3627, Placebo
Longevity Biotech Australia Pty Ltd (subsidiary)
Parkinson Disease
03/25
03/25

Download Options